Single dose comparability study of new and current dupilumab drug products subcutaneously administered in healthy adults

Trial Identifier:	PKM17324
Sponsor:	Sanofi
Collaborator:	Regeneron Pharmaceuticals
Start Date:	June 2021
Primary Completion Date:	September 2021
Study Completion Date:	September 2021
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Florida	Miami, Florida, United States, 33014

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.